Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs (Q37746052)

22 August 2017

1 reference

title

Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs (English)

1 reference

modulation by host of viral process

22 August 2017

0 references

1 reference

0 references

0 references

author

Xavier de Lamballerie

series ordinal

5

object named as

Xavier de Lamballerie

1 reference

22 August 2017

4

Ernest Gould

1 reference

22 August 2017

Boris Pastorino

1

1 reference

PubMed ID

20452379

22 August 2017

Antoine Nougairède

series ordinal

2

1 reference

PubMed ID

20452379

22 August 2017

Nathalie Wurtz

series ordinal

3

1 reference

22 August 2017

7 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

87

1 reference

22 August 2017

3

1 reference

22 August 2017

281-294

1 reference

The non-structural 3 (NS3) protein of dengue virus type 2 interacts with human nuclear receptor binding protein and is associated with alterations in membrane structure

22 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Role of Nonstructural Protein NS2A in Flavivirus Assembly

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Structure of the immature dengue virus at low pH primes proteolytic maturation

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Composition and three-dimensional architecture of the dengue virus replication and assembly sites

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Yellow Fever: 100 Years of Discovery

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Molecular mechanisms of West Nile virus pathogenesis in brain cell

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Cholesterol Effectively Blocks Entry of Flavivirus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Targeting host factors: A novel rationale for the management of hepatitis C virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Therapeutic potential of Toll-like receptor 9 activation

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Novel functions of vimentin in cell adhesion, migration, and signaling

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Cholesterol biosynthesis modulation regulates dengue viral replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Novel binding between pre-membrane protein and vacuolar ATPase is required for efficient dengue virus secretion

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

CLEC5A is critical for dengue-virus-induced lethal disease

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Direct interaction between nucleolin and hepatitis C virus NS5B

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Non-Hemagglutinating Flaviviruses: Molecular Mechanisms for the Emergence of New Strains via Adaptation to European Ticks

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Unchain my heart, baby let me go--the entry and intracellular transport of HIV.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Modulating vaccine responses with dendritic cells and Toll-like receptors

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Challenges and successes in developing new therapies for hepatitis C.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Targeting virulence: a new paradigm for antimicrobial therapy

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Recent advances in flavivirus antiviral drug discovery and vaccine development

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Pathogenesis of flavivirus infections: using and abusing the host cell

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Y box-binding protein-1 binds to the dengue virus 3'-untranslated region and mediates antiviral effects

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Geranylgeranylacetone, an inducer of the 70-kDa heat shock protein (HSP70), elicits unfolded protein response and coordinates cellular fate independently of HSP70.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Hsp70 functions as a negative regulator of West Nile virus capsid protein through direct interaction

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The polypyrimidine tract-binding protein is required for efficient dengue virus propagation and associates with the viral replication machinery

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Structural proteomics of dengue virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

c-Src protein kinase inhibitors block assembly and maturation of dengue virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Does antiviral therapy have a role in the control of Japanese encephalitis?

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

GRP94 reduces cell death in SH-SY5Y cells perturbated calcium homeostasis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Coronavirus spike protein inhibits host cell translation by interaction with eIF3f

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Variegation of the immune response with dendritic cells and pathogen recognition receptors

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Translation elongation factor-1 alpha interacts with the 3' stem-loop region of West Nile virus genomic RNA

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Closing the door on flaviviruses: Entry as a target for antiviral drug design

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

A structural perspective of the flavivirus life cycle

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Identification of human hnRNP C1/C2 as a dengue virus NS1-interacting protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Microarray and real-time RT-PCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Tick-borne encephalitis virus infections in Lithuanian domestic animals and ticks

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Dengue virus pathogenesis: an integrated view

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Rab 5 is required for the cellular entry of dengue and West Nile viruses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Nucleolin is required for an efficient herpes simplex virus type 1 infection.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Molecular chaperone Hsp90 is important for vaccinia virus growth in cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Japanese encephalitis and vaccines: past and future prospects

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The Src Family Kinase c-Yes Is Required for Maturation of West Nile Virus Particles

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Regulated Cleavages at the West Nile Virus NS4A-2K-NS4B Junctions Play a Major Role in Rearranging Cytoplasmic Membranes and Golgi Trafficking of the NS4A Protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Crystal Structure of a Novel Conformational State of the Flavivirus NS3 Protein: Implications for Polyprotein Processing and Viral Replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Immunopathology of flavivirus infections

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Hsp90 inhibitors reduce influenza virus replication in cell culture

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Control of dengue virus translation and replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Nucleolar protein B23 interacts with Japanese encephalitis virus core protein and participates in viral replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

RNA binding properties of core protein of the flavivirus Kunjin

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

La protein binds the predicted loop structures in the 3' non-coding region of Japanese encephalitis virus genome: role in virus replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Experimental Usutu virus infection of suckling mice causes neuronal and glial cell apoptosis and demyelination

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Chaperone-like activity of tubulin. binding and reactivation of unfolded substrate enzymes.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Origins, evolution, and vector/host coadaptations within the genus Flavivirus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Luciferase Imaging of a Neurotropic Viral Infection in Intact Animals

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Exotic emerging viral diseases: progress and challenges

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

West Nile virus-induced bax-dependent apoptosis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Interaction of West Nile virus with primary murine macrophages: role of cell activation and receptors for antibody and complement

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Proteolytic activation of tick-borne encephalitis virus by furin

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

RNA interference screen for human genes associated with West Nile virus infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The mannose receptor mediates dengue virus infection of macrophages

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Highly pathogenic RNA viral infections: challenges for antiviral research.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

3 November 2022

Pathogenic flaviviruses.

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The cellular chaperone heat shock protein 90 facilitates Flock House virus RNA replication in Drosophila cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Viral RNA replication in association with cellular membranes.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Interaction between the Cellular Protein eEF1A and the 3'-Terminal Stem-Loop of West Nile Virus Genomic RNA Facilitates Viral Minus-Strand RNA Synthesis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Structural evidence for regulation and specificity of flaviviral proteases and evolution of theFlaviviridaefold

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Identification of Cellular Proteome Modifications in Response to West Nile Virus Infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Statins inhibit HIV-1 infection by down-regulating Rho activity.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Development and application of Hsp90 inhibitors

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Present perspectives on flaviviral chemotherapy

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Tick-borne encephalitis virus - a review of an emerging zoonosis.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Cholesterol manipulation by West Nile virus perturbs the cellular immune response

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Heat shock effect upon dengue virus replication into U937 cells.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Inhibition of dengue virus replication by mycophenolic acid and ribavirin

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Actin filaments participate in West Nile (Sarafend) virus maturation process

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Protein kinase C delta is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Pathogenesis of viral hemorrhagic fever

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Wrapping things up about virus RNA replication

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

A superhighway to virus infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Modulation of host metabolism as a target of new antivirals

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Chapter 2. New insights into flavivirus nonstructural protein 5.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

RNA interference mediated silencing of Hsp60 gene in human monocytic myeloma cell line U937 revealed decreased dengue virus multiplication.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Proteomic analysis of host responses in HepG2 cells during dengue virus infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Association of Japanese encephalitis virus NS3 protein with microtubules and tumour susceptibility gene 101 (TSG101) protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Role of reactive oxygen intermediates in Japanese encephalitis virus infection in murine neuroblastoma cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Prenylation of HDAg and antiviral drug development

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

Detection and Localization of a Class of Proteins Immunologically Related to a 100-kDa Nucleolar Protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2010.04.014

10.1016/J.ANTIVIRAL.2010.04.014

3 November 2022

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20452379